Evolution of the Average Target: Novartis AG

Evolution of the Target Price: Novartis AG

Changes in Analyst Recommendations: Novartis AG

518bf5325.qB-GVbkoZTzhJ0yoyupxVeUViq_zRNW8vLKAzKBmBBg.-U3MAtBMBkWlRQ3fvoUSMqZZ3cG_EeXey8DZj8QlPUKaUrBkzkwBX6xrHQ~57e0ad78ff62acfb91bf7663be23df26

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+6.53%
+27.49%
+14.05%
+25.15%
+14.42%
+21.89%
+16.48%
+5.87%
+6.44%
+20.36%
Average +15.87%
Weighted average by Cap. +18.19%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
146.30USD
Average target price
155.32USD
Spread / Average Target
+6.16%
High Price Target
178.42USD
Spread / Highest target
+21.95%
Low Price Target
121.07USD
Spread / Lowest Target
-17.25%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

JPMORGAN Richard Vosser
GOLDMAN SACHS James Quigley
alphavalue Abhishek Raval
JEFFERIES
BARCLAYS James Gordon
UBS Matthew Weston
BERNSTEIN RESEARCH Justin Smith
DZ BANK Elmar Kraus
AlphaValue/Baader Europe
Berenberg Bank
BERENBERG
Citigroup
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
Morningstar
Morgan Stanley
Intron Health
Bank Vontobel AG
BNP Paribas Exane
DA Davidson
HSBC
Octavian AG
Jefferies & Co.
Deutsche Bank Securities
Baader Bank
BMO Capital
Kepler Capital Markets
Societe Generale
Redburn
Stifel Nicolaus
BNP Paribas
Barrington Research
International Strategy & Investment Group
Credit Suisse
ODDO BHF
Zacks Equity Research
Bank of America Securities/Merrill Lynch
Kepler Cheuvreux
Wolfe Research
AltaCorp Capital
DEUTSCHE BANK Emmanuel Papadakis
Exane BNP Paribas
Bryan, Garnier & Co.
Moody's Investors Service
Dundee
Exane BNP
Bernstein
Argus
Cowen
BRYAN GARNIER Eric Le Berrigaud
LIBERUM CAPITAL Graham Doyle
BANK OF AMERICA (BOFA) Graham Parry
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
146.30USD
Average target price
155.32USD
Spread / Average Target
+6.16%

Quarterly revenue - Rate of surprise